CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 298.8	$ 322.4
Accounts receivable, net	360.4	357.2
Inventories	541.8	509.6
Other current assets	142.7	115.1
Total current assets	1,343.7	1,304.3
Property, plant and equipment, net	267.6	270.6
Goodwill	275.3	275.7
Operating lease assets	77.4
Intangibles, net and other long-term assets	278.5	278.0
Total assets	2,242.5	2,128.6
Current liabilities:
Current portion of long-term debt	2.6	18.5
Accounts payable	126.5	104.5
Customer advances	132.4	124.4
Other current liabilities	371.2	351.9
Total current liabilities	632.7	599.3
Long-term debt	332.0	322.6
Operating lease liabilities	58.3
Other long-term liabilities	275.7	279.0
Commitments and contingencies (Note 13)
Redeemable noncontrolling interest	22.0	22.6
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding
Common stock, $0.01 par value 260,000,000 shares authorized, 172,836,469 and 172,634,220 shares issued and 156,814,676 and 156,609,340 outstanding at March 31, 2019 and December 31, 2018, respectively	1.7	1.7
Treasury stock, at cost, 16,021,793 and 16,024,880 shares at March 31, 2019 and December 31, 2018, respectively	(401.5)	(401.5)
Accumulated other comprehensive income	3.3	17.0
Other shareholders' equity	1,309.7	1,279.4
Total shareholders' equity attributable to Bruker Corporation	913.2	896.6
Noncontrolling interest in consolidated subsidiaries	8.4	8.5
Total shareholders' equity	921.6	905.1
Total liabilities and shareholders' equity	$ 2,242.3	$ 2,128.6